Physiologic regulation and pathologic disorders of fibrinolysis
- 6 March 1987
- journal article
- review article
- Published by Elsevier in Human Pathology
- Vol. 18 (3), 263-274
- https://doi.org/10.1016/s0046-8177(87)80009-6
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1985
- Coronary thrombolysis and infarct size reduction after intravenous infusion of recombinant tissue-type plasminogen activator in nonhuman primates.JCI Insight, 1985
- The structure of the human tissue-type plasminogen activator gene: correlation of intron and exon structures to functional and structural domains.Proceedings of the National Academy of Sciences, 1984
- Intracoronary thrombolysis with an acylated streptokinase-plasminogen activator (BRL 26921) in patients with acute myocardial infarctionJournal of the American College of Cardiology, 1984
- Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). A study in vitro and in two animal species.JCI Insight, 1984
- Coronary Thrombolysis with Tissue-Type Plasminogen Activator in Patients with Evolving Myocardial InfarctionNew England Journal of Medicine, 1984
- Tissue Plasminogen Activator: Chemical and Physiological AspectsSeminars in Thrombosis and Hemostasis, 1984
- The fibrinolytic system—Basic considerationsProgress in Cardiovascular Diseases, 1979
- The Demise of John HagemanNew England Journal of Medicine, 1968